Cargando…
Nanoparticle-mediated drug delivery to treat infections in the female reproductive tract: evaluation of experimental systems and the potential for mathematical modeling
A variety of drug-delivery platforms have been employed to deliver therapeutic agents across cervicovaginal mucus (CVM) and the vaginal mucosa, offering the capability to increase the longevity and retention of active agents to treat infections of the female reproductive tract (FRT). Nanoparticles (...
Autores principales: | Sims, Lee B, Frieboes, Hermann B, Steinbach-Rankins, Jill M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937491/ https://www.ncbi.nlm.nih.gov/pubmed/29760551 http://dx.doi.org/10.2147/IJN.S160044 |
Ejemplares similares
-
Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer
por: Sims, Lee B., et al.
Publicado: (2016) -
Distribution of PLGA-modified nanoparticles in 3D cell culture models of hypo-vascularized tumor tissue
por: Sims, Lee B., et al.
Publicado: (2017) -
Liquid crystal delivery of ciprofloxacin to treat infections of the female reproductive tract
por: Pisano, Simone, et al.
Publicado: (2019) -
Multicellular Ovarian Cancer Model for Evaluation of Nanovector Delivery in Ascites and Metastatic Environments
por: Winter, Stephen J., et al.
Publicado: (2021) -
BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis–Streptococcus gordonii biofilms
por: Mahmoud, Mohamed Y., et al.
Publicado: (2018)